Quantification of Urinary Thymidine Dimers in Volunteers After Ultraviolet Radiation Using a New UPLC-MS/MS-based Method
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Quantification of Urinary Thymidine Dimers in Volunteers After Ultraviolet Radiation Using a New UPLC-MS/MS-based Method. / Lerche, Catharina M.; Philipsen, Peter A.; Hermansson, Sigurd; Heydenreich, Jakob; Wulf, Hans Christian.
In: Anticancer Research, Vol. 42, No. 10, 2022, p. 5069-5076.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Quantification of Urinary Thymidine Dimers in Volunteers After Ultraviolet Radiation Using a New UPLC-MS/MS-based Method
AU - Lerche, Catharina M.
AU - Philipsen, Peter A.
AU - Hermansson, Sigurd
AU - Heydenreich, Jakob
AU - Wulf, Hans Christian
N1 - Funding Information: The Authors would like to thank laboratory coordinator Kirsten Andersen, Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark for valuable help during innumerable studies during the method development. The research was supported by the Danish Research Center for Skin Cancer, Denmark (https://vfhk.org/en) and the Skin Cancer Innovation Clinical Academic Group (SCIN CAG), Greater Copenhagen Health Science Partners (GCHSP), Copenhagen, Denmark. The work was funded by Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark. C.M.L is funded by the Lundbeck Foundation, Copenhagen, Denmark (R307-2018-3318).
PY - 2022
Y1 - 2022
N2 - Background/Aim: Solar ultraviolet radiation (UVR) is a carcinogen and irradiation of the skin results in DNA damage. Cyclobutane pyrimidine dimers (CPDs), including thymidine dimers, are among the most frequent forms of DNA damage. When CPDs are formed, the nucleotide excision repair system is activated and CPDs are excreted in the urine. Here, we developed a mass spectrometry-based method to quantify thymidine dimers in the urine and tested the method on a small group of volunteers after whole-body UVR exposure. Patients and Methods: Years of research resulted in a method based on the “dilute-and-shoot” principle and ultra-performance liquid chromatography (UPLC) coupled to mass spectrometry. The whole body of each of eight healthy volunteers was exposed to 1.5-2.0 standard erythema doses (SEDs) of UVR for 3 consecutive days. Morning urine was collected on Day 1 (before irradiation) and on the following 7-9 days. Prior to analysis, sample preparation consisted of a simple dilution. A tandem quadrupole mass spectrometer coupled to UPLC was used for quantitative analysis in the multiple reaction monitoring mode. Results: After 3 consecutive days of 1.5-2 SEDs, the highest level of thymidine dimer excretion occurred on Day 6 (0.7 ng/ml urine). Compared with baseline, significantly more thymidine dimers were excreted every day until Day 8 (p<0.016). Our method quantifies thymidine dimers that are excreted as dimers (i.e., not degraded further) after nucleotide excision repair. Conclusion: This is the first published mass spectrometry-based method for quantifying thymidine dimers in the urine after whole-body UVR exposure.
AB - Background/Aim: Solar ultraviolet radiation (UVR) is a carcinogen and irradiation of the skin results in DNA damage. Cyclobutane pyrimidine dimers (CPDs), including thymidine dimers, are among the most frequent forms of DNA damage. When CPDs are formed, the nucleotide excision repair system is activated and CPDs are excreted in the urine. Here, we developed a mass spectrometry-based method to quantify thymidine dimers in the urine and tested the method on a small group of volunteers after whole-body UVR exposure. Patients and Methods: Years of research resulted in a method based on the “dilute-and-shoot” principle and ultra-performance liquid chromatography (UPLC) coupled to mass spectrometry. The whole body of each of eight healthy volunteers was exposed to 1.5-2.0 standard erythema doses (SEDs) of UVR for 3 consecutive days. Morning urine was collected on Day 1 (before irradiation) and on the following 7-9 days. Prior to analysis, sample preparation consisted of a simple dilution. A tandem quadrupole mass spectrometer coupled to UPLC was used for quantitative analysis in the multiple reaction monitoring mode. Results: After 3 consecutive days of 1.5-2 SEDs, the highest level of thymidine dimer excretion occurred on Day 6 (0.7 ng/ml urine). Compared with baseline, significantly more thymidine dimers were excreted every day until Day 8 (p<0.016). Our method quantifies thymidine dimers that are excreted as dimers (i.e., not degraded further) after nucleotide excision repair. Conclusion: This is the first published mass spectrometry-based method for quantifying thymidine dimers in the urine after whole-body UVR exposure.
KW - bioanalysis
KW - CPD
KW - cyclobutane pyrimidine dimer
KW - DNA damage
KW - LC-MS/MS
KW - thymidine dimer
KW - urine
U2 - 10.21873/anticanres.16015
DO - 10.21873/anticanres.16015
M3 - Journal article
C2 - 36191964
AN - SCOPUS:85139159407
VL - 42
SP - 5069
EP - 5076
JO - Anticancer Research
JF - Anticancer Research
SN - 0250-7005
IS - 10
ER -
ID: 322790815